Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
ChemMedChem
2025
|
| Sujets: | |
| Accès en ligne: | https://pubmed.ncbi.nlm.nih.gov/39688580/ |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1868266268203679745 |
|---|---|
| author | Tisseur, Lhana Cojean, Sandrine Gassama, Khadidiatou Logé, Cédric Pagniez, Fabrice Cavé, Christian Bernadat, Guillaume Loiseau, Philippe M Bach, Stéphane Thiéfaine, Jérôme Picot, Carine Tomasoni, Christophe Leclercq, Olivier Baratte, Blandine Robert, Thomas Le Pape, Patrice Rachidi, Najma Bazin, Marc-Antoine Marchand, Pascal |
| author_facet | Tisseur, Lhana Cojean, Sandrine Gassama, Khadidiatou Logé, Cédric Pagniez, Fabrice Cavé, Christian Bernadat, Guillaume Loiseau, Philippe M Bach, Stéphane Thiéfaine, Jérôme Picot, Carine Tomasoni, Christophe Leclercq, Olivier Baratte, Blandine Robert, Thomas Le Pape, Patrice Rachidi, Najma Bazin, Marc-Antoine Marchand, Pascal Tisseur, Lhana Cojean, Sandrine Gassama, Khadidiatou Logé, Cédric Pagniez, Fabrice Cavé, Christian Bernadat, Guillaume Loiseau, Philippe M Bach, Stéphane Thiéfaine, Jérôme Picot, Carine Tomasoni, Christophe Leclercq, Olivier Baratte, Blandine Robert, Thomas Le Pape, Patrice Rachidi, Najma Bazin, Marc-Antoine Marchand, Pascal |
| collection | PubMed - marine biology |
| contents | Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. Tisseur, Lhana Cojean, Sandrine Gassama, Khadidiatou Logé, Cédric Pagniez, Fabrice Cavé, Christian Bernadat, Guillaume Loiseau, Philippe M Bach, Stéphane Thiéfaine, Jérôme Picot, Carine Tomasoni, Christophe Leclercq, Olivier Baratte, Blandine Robert, Thomas Le Pape, Patrice Rachidi, Najma Bazin, Marc-Antoine Marchand, Pascal Casein Kinase I Antiprotozoal Agents Structure-Activity Relationship Pyrazines Leishmania donovani Protein Kinase Inhibitors Leishmania major Animals Molecular Structure Imidazoles Dose-Response Relationship, Drug Macrophages Parasitic Sensitivity Tests Humans Mice Our research group previously discovered CTN1122, an imidazo[1,2-a]pyrazine compound with promising antileishmanial activity against intramacrophage amastigotes of Leishmania major and L. donovani strains. CTN1122 effectively targets Leishmania casein kinase 1 (L-CK1.2) and exhibits a favorable safety profile. To further explore its chemical space, we developed a convergent strategy to modify the C2 position of the imidazo[1,2-a]pyrazine core using Suzuki-Miyaura coupling of the corresponding triflate intermediate. Among 15 newly synthesized analogs, seven derivatives featuring variously substituted phenyl rings at C2 demonstrated L-CK1.2 inhibition within micromolar to submicromolar ranges and antileishmanial activity in vitro with low cytotoxicity in macrophages. Compounds 7 d and 7 l were particularly potent, with IC values of 1.25 μM and 0.92 μM against L. major, and 1.44 μM and 2.34 μM against L. donovani, respectively. They showed IC L-CK1.2=0.30 μM and 0.57 μM with enhanced selectivity indices (SI=3.8 and 1.6) over the human CK1ϵ ortholog. Additionally, four C2 analogs and two C5 isomers exhibited notable antiparasitic effects without strongly inhibiting L-CK1.2, indicating a possible alternative mechanism of action. Compound 7 k displayed the highest general activity, with IC values of 0.31 μM on L. major and 0.27 μM on L. donovani, coupled with favorable selectivity indexes. |
| format | Artículo científico |
| id | pubmed_39688580 |
| institution | PubMed |
| language | en |
| publishDate | 2025 |
| publisher | ChemMedChem |
| record_format | pubmed |
| spellingShingle | Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. Tisseur, Lhana Cojean, Sandrine Gassama, Khadidiatou Logé, Cédric Pagniez, Fabrice Cavé, Christian Bernadat, Guillaume Loiseau, Philippe M Bach, Stéphane Thiéfaine, Jérôme Picot, Carine Tomasoni, Christophe Leclercq, Olivier Baratte, Blandine Robert, Thomas Le Pape, Patrice Rachidi, Najma Bazin, Marc-Antoine Marchand, Pascal Casein Kinase I Antiprotozoal Agents Structure-Activity Relationship Pyrazines Leishmania donovani Protein Kinase Inhibitors Leishmania major Animals Molecular Structure Imidazoles Dose-Response Relationship, Drug Macrophages Parasitic Sensitivity Tests Humans Mice Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. Tisseur, Lhana Cojean, Sandrine Gassama, Khadidiatou Logé, Cédric Pagniez, Fabrice Cavé, Christian Bernadat, Guillaume Loiseau, Philippe M Bach, Stéphane Thiéfaine, Jérôme Picot, Carine Tomasoni, Christophe Leclercq, Olivier Baratte, Blandine Robert, Thomas Le Pape, Patrice Rachidi, Najma Bazin, Marc-Antoine Marchand, Pascal Casein Kinase I Antiprotozoal Agents Structure-Activity Relationship Pyrazines Leishmania donovani Protein Kinase Inhibitors Leishmania major Animals Molecular Structure Imidazoles Dose-Response Relationship, Drug Macrophages Parasitic Sensitivity Tests Humans Mice Our research group previously discovered CTN1122, an imidazo[1,2-a]pyrazine compound with promising antileishmanial activity against intramacrophage amastigotes of Leishmania major and L. donovani strains. CTN1122 effectively targets Leishmania casein kinase 1 (L-CK1.2) and exhibits a favorable safety profile. To further explore its chemical space, we developed a convergent strategy to modify the C2 position of the imidazo[1,2-a]pyrazine core using Suzuki-Miyaura coupling of the corresponding triflate intermediate. Among 15 newly synthesized analogs, seven derivatives featuring variously substituted phenyl rings at C2 demonstrated L-CK1.2 inhibition within micromolar to submicromolar ranges and antileishmanial activity in vitro with low cytotoxicity in macrophages. Compounds 7 d and 7 l were particularly potent, with IC values of 1.25 μM and 0.92 μM against L. major, and 1.44 μM and 2.34 μM against L. donovani, respectively. They showed IC L-CK1.2=0.30 μM and 0.57 μM with enhanced selectivity indices (SI=3.8 and 1.6) over the human CK1ϵ ortholog. Additionally, four C2 analogs and two C5 isomers exhibited notable antiparasitic effects without strongly inhibiting L-CK1.2, indicating a possible alternative mechanism of action. Compound 7 k displayed the highest general activity, with IC values of 0.31 μM on L. major and 0.27 μM on L. donovani, coupled with favorable selectivity indexes. |
| title | Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition. |
| topic | Casein Kinase I Antiprotozoal Agents Structure-Activity Relationship Pyrazines Leishmania donovani Protein Kinase Inhibitors Leishmania major Animals Molecular Structure Imidazoles Dose-Response Relationship, Drug Macrophages Parasitic Sensitivity Tests Humans Mice |
| url | https://pubmed.ncbi.nlm.nih.gov/39688580/ |